We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




New Breast Implants Contain RFID Technology

By HospiMedica International staff writers
Posted on 02 Mar 2014
Breast implants with radiofrequency identification (RFID) chips can be simply externally scanned for retrieval of information in the event of a recall or other product query.

The Motiva Implant Matrix VelvetSurface PLUS and SilkSurface PLUS breast implants are a made of a soft, gliding, printed nanosurface that reduces complications related to traditional textures, while at the same time reducing capsular contracture rates. More...
The VelvetSurface PLUS implants also provide a printed microsurface that promotes a more secure fit in the breast pocket. Both breast implants are provided with Q Inside Safety Technology, which acts as an electronic serial identification number in breast implants and other implantable and reusable medical devices.

Manufacturers, physicians, and patients alike will have access to a secure online database to retrieve implant-specific data such as serial number, manufacturer name, date of manufacture, lot number, volume, size, and other data from the medical device manufacturer. The Motiva Implant Matrix VelvetSurface PLUS and SilkSurface PLUS breast implants are products of Establishment Labs (Alajuela, Costa Rica). Q Inside Safety Technology was developed by VeriTeQ Corporation (DelRay Beach, FL, USA), a provider of implantable medical device identification and radiation dose measurement technologies.

“We continue to advance the safety and exclusivity of our entire breast implant portfolio to answer the demands from both physicians and patients alike,” said Juan José Chacón-Quirós, CEO of Establishment Labs. “Including VeriTeQ’s Q Inside Safety Technology in Motiva’s SilkSurface PLUS and VelvetSurface PLUS implants emphasizes our primary focus of providing best-in-class products for the protection of the patient.”

“Giving physicians and patients the power to identify their breast implants in a healthcare setting is the next generation of technology and security, and we believe both groups will ultimately demand this level of safety from their implants,” said Scott R. Silverman, chairman and CEO of VeriTeQ.

A example highlighting the need for breast implant identification occurred in 2010, when a French manufacturer of breast implants named PIP was shut down because the company used industrial grade silicone in their implants instead of medical-grade silicone, which had double the rupture rate of other implants. As news of leaks spread, breast implant patients were concerned that they may have PIP's implants. Many of the patients did not have product or warranty cards, and no records were available on which implants were inside each patient.

Related Links:

Establishment Labs
VeriTeQ Corporation



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Infusion System
SIGMA Spectrum
New
Ultra-Low Temperature Freezer
iUF118-GX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A mechanosensing-based approach offers a potential path to the treatment for cardiac fibrosis (Photo courtesy of Adobe Stock)

Mechanosensing-Based Approach Offers Promising Strategy to Treat Cardiovascular Fibrosis

Cardiac fibrosis, which involves the stiffening and scarring of heart tissue, is a fundamental feature of nearly every type of heart disease, from acute ischemic injuries to genetic cardiomyopathies.... Read more

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.